Notice of Intent to Sole Source – BD BIOSCIENCES

The National Institutes of Health Clinical Center, under the Department of Health and Human Services, is issuing a Notice of Intent to Sole Source a five-year service contract for preventive maintenance and emergency servicing of specialized laboratory equipment used in clinical research and cellular therapy product development. The procurement covers two BD FACSLyric flow cytometers with Universal Loaders and two BD Lyse/Wash Assistants that are critical for processing patient samples, identifying cell populations, and supporting FDA-regulated product licensing and release decisions for over 50 intramural clinical trials. BD Biosciences is identified as the sole vendor capable of providing the required periodic preventive maintenance due to the proprietary nature of the equipment and FDA 21 CFR compliance requirements. The contract is being conducted under FAR Part 13 Simplified Acquisition Procedures, which permits single-source solicitation when circumstances deem only one source reasonably available. Interested parties may submit comments referencing notice number NOI-OD-26-003977 to Ryssa Nix, Contract Specialist, at Ryssa.nix@nih.gov, with a comment submission deadline of March 25, 2026.

No set-aside designations apply to this procurement. BD Biosciences is the incumbent contractor and sole source for these services. The total contract value is $318,511.20 over the five-year period, with an annual renewal rate of $63,702.24. Service requirements include one preventive maintenance inspection and one PM kit per contract year, unlimited software revisions, unlimited service visits five days per week with 24-hour guaranteed emergency response, and unlimited telephone support at no additional cost. The contract period spans from the Base Year of April 1, 2026 through March 31, 2027, followed by four option years extending through March 31, 2031, with services provided during normal business hours Monday through Friday, excluding federal holidays.